Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
ISA Pharmaceuticals
company
About
ISA Pharmaceuticals is a developer of synthetic therapeutic vaccines designed to provide treatment for cancer.
- 1 - 10
Highlights
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- €20M
- Industries
- Biotechnology,Medical
- Founded date
- Jan 1, 2004
- Number Of Employee
- 1 - 10
- Operating Status
- Active
ISA Pharmaceuticals B.V. is a clinical-stage immunotherapy company developing rationally designed, fully synthetic immunotherapeutics against cancer and persistent virus infections. The Company has built a proprietary immunotherapy platform based on its Synthetic Long Peptide (SLP®) concept and its AMPLIVANT® technology. SLP® immunotherapies are designed to fully harness and direct the body’s own defense mechanisms towards fighting the disease, either alone or in combination with existing therapies.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€20M
ISA Pharmaceuticals has raised a total of
€20M
in funding over 2 rounds. Their latest funding was raised on
Oct 14, 2019 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 14, 2019 | Debt Financing | €20M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
ISA Pharmaceuticals is funded by 1 investors.
European Investment Bank
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
European Investment Bank
|
— | Debt Financing |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
